Semler Scientific, which sells devices that measure arterial blood flow in patients, announced terms for its IPO on Friday. The Portland, OR-based company plans to raise $15 million by offering 1.2 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Semler Scientific would command a fully diluted market value of $62 million. Semler Scientific, which was founded in 2007 and booked $2 million in sales for the 12 months ended 9/30/2013, plans to list on the NASDAQ under the symbol SMLR. Semler Scientific initially filed confidentially on 10/10/2013. Aegis Capital Corp. is the sole bookrunner on the deal.
